Abnormal Von Willebrand Factor Multimer Distribution C4022617
A bleeding disorder caused by abnormal distribution of a key blood clotting protein, leading to impaired clot formation. Treatment involves medications that help improve clotting function.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Mucosal bleeding tendency
Hemarthrosis
Deep tissue hemorrhage
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Prolonged wound bleeding
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Desmopressin (DDAVP) therapy
Synthetic hormone administration to stimulate release of von Willebrand factor from endothelial cells, improving clotting function in type 1 and some type 2 cases.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Antifibrinolytic agents
Administration of tranexamic acid or aminocaproic acid to stabilize clots by preventing fibrin degradation, particularly useful for mucosal bleeding.
Additional treatment options
Bleeding precautions and avoidance of NSAIDs
Patient education on avoiding anticoagulants, NSAIDs, and activities with high injury risk, along with maintaining emergency medical identification.
lifestyleVon Willebrand factor concentrate infusion
Replacement therapy with virally inactivated plasma-derived concentrates for severe bleeding or surgical prophylaxis in types 2 and 3.
procedureRegular hematologic monitoring
Scheduled laboratory assessment of VWF levels, factor VIII, and multimer analysis to guide prophylactic therapy and surgical planning.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Medication Comparisons
Compare medications used to treat Abnormal Von Willebrand Factor Multimer Distribution C4022617. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy